Everhart Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.37M Sell
25,328
-1,078
-4% -$232K 0.41% 33
2026
Q1
$5.74M Buy
26,406
+5,756
+28% +$1.28M 0.49% 31
2025
Q4
$4.72M Buy
20,650
+639
+3% +$146K 0.44% 28
2025
Q3
$4.63M Buy
20,011
+958
+5% +$195K 0.46% 30
2025
Q2
$3.54M Buy
19,053
+676
+4% +$126K 0.41% 36
2025
Q1
$3.85M Buy
18,377
+1,097
+6% +$213K 0.53% 32
2024
Q4
$3.07M Buy
17,280
+4,295
+33% +$790K 0.63% 33
2024
Q3
$2.56M Buy
12,985
+1,299
+11% +$242K 0.57% 33
2024
Q2
$2M Buy
11,686
+990
+9% +$164K 0.52% 34
2024
Q1
$1.95M Buy
10,696
+4,059
+61% +$700K 0.57% 35
2023
Q4
$1.03M Sell
6,637
-579
-8% -$84.4K 0.36% 56
2023
Q3
$1.08M Buy
7,216
+1,064
+17% +$156K 0.46% 48
2023
Q2
$829K Sell
6,152
-836
-12% -$123K 0.34% 62
2023
Q1
$1.11M Buy
6,988
+442
+7% +$67.6K 0.5% 41
2022
Q4
$1.06M Buy
6,546
+535
+9% +$82K 0.53% 40
2022
Q3
$806K Buy
6,011
+438
+8% +$62.9K 0.45% 41
2022
Q2
$853K Buy
5,573
+1,288
+30% +$197K 0.52% 39
2022
Q1
$694K Buy
4,285
+1,484
+53% +$216K 0.4% 50
2021
Q4
$379K Buy
+2,801
New +$331K 0.23% 82
2021
Q3
Sell
-2,473
Closed -$278K 102
2021
Q2
$278K Buy
+2,473
New +$279K 0.19% 78

Other funds holding ABBV

Everhart Financial Group's ABBV Position: Q2 2026 in Review

Everhart Financial Group reduced its AbbVie (ABBV) stake by 4.1% in Q2 2026, selling an estimated $232K and leaving 25,328 shares worth $6.37M. The position accounts for 0.41% of the portfolio, ranked #33.

Everhart Financial Group first reported a position in ABBV in Q2 2021 and has held it in 20 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Everhart Financial Group held 25,328 shares of AbbVie worth $6.37M as of Q2 2026.
  • Everhart Financial Group sold 1,078 AbbVie shares in Q2 2026, an estimated $232K.
  • AbbVie made up 0.41% of Everhart Financial Group's portfolio in Q2 2026, its #33 holding.
  • Everhart Financial Group first reported a position in AbbVie in Q2 2021 and has held it in 20 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.